Quarterly Statement Of Cash Flows

COSMOS Pharmaceutical Corporation - Filing #7288705

Concept As at
2024-11-30
2024-06-01 to
2024-11-30
As at
2024-05-31
As at
2023-11-30
2023-06-01 to
2023-11-30
As at
2023-05-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
19,843,000,000 JPY
21,318,000,000 JPY
Interest and dividends received
0 JPY
0 JPY
Interest paid
-97,000,000 JPY
-35,000,000 JPY
Income taxes paid
-4,823,000,000 JPY
-4,335,000,000 JPY
Net cash provided by (used in) operating activities
15,087,000,000 JPY
16,948,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-21,475,000,000 JPY
-27,506,000,000 JPY
Proceeds from sale of property, plant and equipment
JPY
3,000,000 JPY
Other, net
-535,000,000 JPY
-461,000,000 JPY
Net cash provided by (used in) investing activities
-22,511,000,000 JPY
-28,545,000,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-2,290,000,000 JPY
-1,370,000,000 JPY
Purchase of treasury shares
-1,000,000 JPY
JPY
Dividends paid
-2,380,000,000 JPY
-2,279,000,000 JPY
Net cash provided by (used in) financing activities
-5,748,000,000 JPY
-4,634,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
-13,172,000,000 JPY
-16,232,000,000 JPY
Cash and cash equivalents
39,129,000,000 JPY
52,301,000,000 JPY
29,696,000,000 JPY
45,928,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.